0001531984-14-000001.txt : 20140825 0001531984-14-000001.hdr.sgml : 20140825 20140825141117 ACCESSION NUMBER: 0001531984-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140825 DATE AS OF CHANGE: 20140825 EFFECTIVENESS DATE: 20140825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALDEA Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001531984 IRS NUMBER: 271252516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-223549 FILM NUMBER: 141062256 BUSINESS ADDRESS: STREET 1: 3696 HAVEN AVE., SUITE C CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650 241-1600 MAIL ADDRESS: STREET 1: 3696 HAVEN AVE., SUITE C CITY: REDWOOD CITY STATE: CA ZIP: 94063 D 1 primary_doc.xml X0707 D LIVE 0001531984 ALDEA Pharmaceuticals, Inc. 3696 HAVEN AVE., SUITE C REDWOOD CITY CA CALIFORNIA 94063 650 241-1600 DELAWARE None None Corporation true Timothy Shannon c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Director William Yelle c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Executive Officer Director Wende Hutton c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Director Wenjin Yang c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Executive Officer Howard Rosen c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Director John Walker c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Director Richard Shames, M.D. c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Executive Officer Vernon Jiang, Ph.D. c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Executive Officer Evgeny Zaytsev c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Director Biotechnology Decline to Disclose 06b false 2014-08-11 false true true Offering of convertible promissory notes ("Notes"), Series B Preferred Stock ("Series B"), the underlying shares of Series B issuable upon conversion of Notes and the underlying shares of Common Stock issuable upon conversion of Series B. false 0 24058143 9262658 14795485 false 5 0 0 0 true false ALDEA Pharmaceuticals, Inc. /s/ William E. Yelle William E. Yelle Chief Executive Officer 2014-08-21